Please login to the form below

Not currently logged in
Email:
Password:

Immunology

This page shows the latest Immunology news and features for those working in and with pharma, biotech and healthcare.

Boehringer beefs up biologics capacity with €230m investment

Boehringer beefs up biologics capacity with €230m investment

In particular, the BDC will support Boehringer’s push into immunology and immuno-oncology.

Latest news

More from news
Approximately 8 fully matching, plus 172 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Back in June 2015 Celgene and Juno announced a ten-year collaboration to combine their respective immunology expertise to develop new immunotherapies for cancer and autoimmune diseases based on T cell

  • The good, the bad and the ugly The good, the bad and the ugly

    selling drug until its patent expiry in the US in 2023, ”says Alexandra Annis, senior analyst, immunology, GlobalData. ... The immunology market has seen setbacks too, with sales at both Pfizer (-3.6%) and Amgen (-10.8%) notably declining.

  • Digital disruption Digital disruption

    Clearly these aren’t isolated examples. Pfizer has teamed up with IBM to accelerate its search for immunology treatments, hoping to identify new drug treatments.

  • Taking a lean and careful approach Taking a lean and careful approach

    with a promising pipeline across multiple programmes for oncology and immunology.

  • Deal Watch November 2016 Deal Watch November 2016

    malignancies. As with PD-1 and other checkpoints, TAMs regulate the immune response to cancer and therefore TAMs have broad application and potential across immuno-oncology and immunology.

More from intelligence
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 66 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    Allergy Therapeutics - Allergy products. CSL Behring - Corporate, Critical care, Immunology.

  • Biotech: it's a people business

    From Johnson &Johnson’ s immunology treatments to Pfizer’ s work on a stem cell-based remedy for age-related macular degeneration, pharma companies are quickly realising biotechnology is the future of

  • Perspective on biotech

    Perspective on biotech. In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating. Biotech companies operate in highly complex

  • TVF Communications shortlisted for the Writing Excellence award at Communique 2016

    TVF Communications shortlisted for the Writing Excellence award at Communique 2016. TVF Communications; an independent, global healthcare communications agency, has been shortlisted for the Writing Excellence – Digital / Online Content Award at

  • VCCP Health Appoints New Creative Team

    Not only do they bring experience working on Rx accounts such as the immunology biosimilar portfolio for Novartis, but passion and expertise for animal health, disease awareness and charity work. “

More from PMHub
Approximately 3 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics